Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Allissa M. Long, PharmD and Kevin W. Chamberlin, PharmD, FASCP
Advertisement
Articles by Allissa M. Long, PharmD and Kevin W. Chamberlin, PharmD, FASCP
Advertisement
Latest Updated Articles
Lefamulin (Xenleta) for Community Acquired Bacterial PneumoniaJanuary 21st 2020
Advertisement
Advertisement
Trending on Drug Topics
1
Serotype 34 Causes Pneumococcal Meningitis in Child With Cochlear Implants
2
Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes
3
FDA Approves Once-Monthly Olanzapine Injection for Adults with Schizophrenia
4
American Pharmacists Month: The Many Career Paths US Pharmacists Explore
5